These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 27449046)

  • 1. A novel colchicine-based microtubule inhibitor exhibits potent antitumor activity by inducing mitochondrial mediated apoptosis in MIA PaCa-2 pancreatic cancer cells.
    Kumar A; Singh B; Mahajan G; Sharma PR; Bharate SB; Mintoo MJ; Mondhe DM
    Tumour Biol; 2016 Oct; 37(10):13121-13136. PubMed ID: 27449046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel microtubule depolymerizing colchicine analogue triggers apoptosis and autophagy in HCT-116 colon cancer cells.
    Kumar A; Singh B; Sharma PR; Bharate SB; Saxena AK; Mondhe DM
    Cell Biochem Funct; 2016 Mar; 34(2):69-81. PubMed ID: 26919061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leiodermatolide, a novel marine natural product, has potent cytotoxic and antimitotic activity against cancer cells, appears to affect microtubule dynamics, and exhibits antitumor activity.
    Guzmán EA; Xu Q; Pitts TP; Mitsuhashi KO; Baker C; Linley PA; Oestreicher J; Tendyke K; Winder PL; Suh EM; Wright AE
    Int J Cancer; 2016 Nov; 139(9):2116-26. PubMed ID: 27376928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells.
    Yan J; Pang Y; Sheng J; Wang Y; Chen J; Hu J; Huang L; Li X
    Biochem Pharmacol; 2015 Sep; 97(1):51-61. PubMed ID: 26212540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colchicine derivatives with potent anticancer activity and reduced P-glycoprotein induction liability.
    Singh B; Kumar A; Joshi P; Guru SK; Kumar S; Wani ZA; Mahajan G; Hussain A; Qazi AK; Kumar A; Bharate SS; Gupta BD; Sharma PR; Hamid A; Saxena AK; Mondhe DM; Bhushan S; Bharate SB; Vishwakarma RA
    Org Biomol Chem; 2015 May; 13(20):5674-89. PubMed ID: 25895604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo.
    Xia Y; Lei Q; Zhu Y; Ye T; Wang N; Li G; Shi X; Liu Y; Shao B; Yin T; Zhao L; Wu W; Song X; Xiong Y; Wei Y; Yu L
    Cancer Lett; 2014 Dec; 355(2):297-309. PubMed ID: 25301449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrrolotetrazinones deazaanalogues of temozolomide induce apoptosis in Jurkat cell line: involvement of tubulin polymerization inhibition.
    Viola G; Cecconet L; Leszl A; Basso G; Brun P; Salvador A; Dall'Acqua F; Diana P; Barraja P; Cirrincione G
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1235-51. PubMed ID: 19363609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DAT-230, a novel microtubule inhibitor, exhibits potent anti-tumor activity by inducing G2/M phase arrest, apoptosis in vitro and perfusion decrease in vivo to HT-1080.
    Qiao F; Zuo D; Shen X; Qi H; Wang H; Zhang W; Wu Y
    Cancer Chemother Pharmacol; 2012 Aug; 70(2):259-70. PubMed ID: 22752214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An oral quinoline derivative, MPT0B392, causes leukemic cells mitotic arrest and overcomes drug resistant cancer cells.
    Chao MW; Huang HL; HuangFu WC; Hsu KC; Liu YM; Wu YW; Lin CF; Chen YL; Lai MJ; Lee HY; Liou JP; Teng CM; Yang CR
    Oncotarget; 2017 Apr; 8(17):27772-27785. PubMed ID: 28186963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo.
    Kuo CC; Hsieh HP; Pan WY; Chen CP; Liou JP; Lee SJ; Chang YL; Chen LT; Chen CT; Chang JY
    Cancer Res; 2004 Jul; 64(13):4621-8. PubMed ID: 15231674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YSL-12, a novel microtubule-destabilizing agent, exerts potent anti-tumor activity against colon cancer in vitro and in vivo.
    Cai D; Qiu Z; Yao W; Liu Y; Huang H; Liao S; Luo Q; Xie L; Lin Z
    Cancer Chemother Pharmacol; 2016 Jun; 77(6):1217-29. PubMed ID: 27107592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel bis-indole destabilizes microtubules and displays potent in vitro and in vivo antitumor activity in prostate cancer.
    Ahn S; Hwang DJ; Barrett CM; Yang J; Duke CB; Miller DD; Dalton JT
    Cancer Chemother Pharmacol; 2011 Feb; 67(2):293-304. PubMed ID: 20383708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo anticancer potential and molecular targets of the new colchicine analog IIIM-067.
    Malik S; Mintoo MJ; Reddy CN; Kumar R; Kotwal P; Bharate SB; Nandi U; Mondhe DM; Shukla SK
    J Integr Med; 2023 Jan; 21(1):62-76. PubMed ID: 36253285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel analogue of colchicine induces selective pro-death autophagy and necrosis in human cancer cells.
    Larocque K; Ovadje P; Djurdjevic S; Mehdi M; Green J; Pandey S
    PLoS One; 2014; 9(1):e87064. PubMed ID: 24466327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic activity and antitumor efficacy of PEGylated TNF-related apoptosis-inducing ligand (TRAIL) in a Mia Paca-2 cell-xenografted mouse model.
    Byeon HJ; Choi SH; Choi JS; Kim TH; Lee ES; Lee KC; Youn YS
    Biomed Pharmacother; 2014 Feb; 68(1):65-9. PubMed ID: 24268811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
    Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S
    Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine induces autophagy and senescence in lung cancer cells at clinically admissible concentration: potential use of colchicine in combination with autophagy inhibitor in cancer therapy.
    Bhattacharya S; Das A; Datta S; Ganguli A; Chakrabarti G
    Tumour Biol; 2016 Aug; 37(8):10653-64. PubMed ID: 26867767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cladosporol A triggers apoptosis sensitivity by ROS-mediated autophagic flux in human breast cancer cells.
    Koul M; Kumar A; Deshidi R; Sharma V; Singh RD; Singh J; Sharma PR; Shah BA; Jaglan S; Singh S
    BMC Cell Biol; 2017 Jul; 18(1):26. PubMed ID: 28728544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Miltirone exhibits antileukemic activity by ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction pathways.
    Zhou L; Jiang L; Xu M; Liu Q; Gao N; Li P; Liu EH
    Sci Rep; 2016 Feb; 6():20585. PubMed ID: 26848099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective killing of gastric cancer cells by a small molecule targeting ROS-mediated ER stress activation.
    Zou P; Xia Y; Chen T; Zhang J; Wang Z; Chen W; Chen M; Kanchana K; Yang S; Liang G
    Mol Carcinog; 2016 Jun; 55(6):1073-86. PubMed ID: 26086416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.